In Silico Evaluation of NO-Sartans against SARS-CoV-2

CONCLUSION: Based on our in silico studies, CLC-1280 (a Valsartan dinitrate) has the potential to be considered as an inhibitor of the SARS-CoV-2 virus. However, further in vitro and in vivo evaluations are necessary for the drug development process.PMID:38445698 | DOI:10.2174/0115701638279362240223070810

Source: Current Drug Discovery Technologies - March 6, 2024 Category: Drugs & Pharmacology Authors: Negar Omidkhah Farzin Hadizadeh Razieh Ghodsi Prashant Kesharwani Amirhossein Sahebkar Source Type: research